| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 304 |
| 1 | LETROZOLE TABLETS | 257 |
| 2 | FULVESTRANT | 253 |
| 3 | RIBOCICLIB | 242 |
| 4 | PALBOCICLIB | 177 |
| 5 | DENOSUMAB | 141 |
| 6 | ZOLEDRONIC ACID | 107 |
| 7 | CAPECITABINE | 103 |
| 8 | ANASTROZOLE | 98 |
| 9 | ANASTROZOLE TABLETS | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FULVESTRANT | 253 | 0.0075 |
| 1 | RIBOCICLIB | 242 | 0.0074 |
| 2 | LETROZOLE TABLETS | 257 | 0.0053 |
| 3 | LETROZOLE | 304 | 0.0049 |
| 4 | IBANDRONATE SODIUM | 13 | 0.0041 |
| 5 | GOSERELIN | 52 | 0.0038 |
| 6 | ANASTROZOLE TABLETS | 77 | 0.0035 |
| 7 | VINORELBINE | 24 | 0.0034 |
| 8 | EXEMESTANE | 74 | 0.0034 |
| 9 | CAPIVASERTIB | 9 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 409 |
| 1 | Estrogen Receptor Antagonist [EPC] | 264 |
| 2 | Kinase Inhibitor [EPC] | 254 |
| 3 | RANK Ligand Inhibitor [EPC] | 141 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 123 |
| 5 | Microtubule Inhibitor [EPC] | 70 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 66 |
| 7 | Alkylating Drug [EPC] | 55 |
| 8 | Calcium [EPC] | 39 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 264 | 0.0065 |
| 1 | Aromatase Inhibitor [EPC] | 409 | 0.0036 |
| 2 | Provitamin D2 Compound [EPC] | 36 | 0.0012 |
| 3 | RANK Ligand Inhibitor [EPC] | 141 | 0.0007 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 38 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 10 | 0.0005 |
| 7 | Kinase Inhibitor [EPC] | 254 | 0.0005 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 123 | 0.0004 |
| 9 | Microtubule Inhibitor [EPC] | 70 | 0.0004 |